FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.4  |  FHIR Version n/a  User: [n/a]

1037671000168100: daratumumab (AU substance)


Status: current, Primitive. Date: 30-Nov 2017. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
2135641000168110 daratumumab (AU substance) en Fully specified name Active Case sensitive Australian Medicines Terminology module
2135651000168112 daratumumab en Synonym Active Case sensitive Australian Medicines Terminology module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
daratumumab Is a medicinal substance true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Darzalex SC 1.8 g/15 mL injection, 15 mL vial has intended active ingredient True daratumumab Inferred relationship Some 612652602
Darzalex SC 1.8 g/15 mL injection, 15 mL vial has Australian BoSS True daratumumab Inferred relationship Some 612652602
daratumumab 1.8 g/15 mL injection, vial has Australian BoSS True daratumumab Inferred relationship Some 418201394
daratumumab 1.8 g/15 mL injection, vial has intended active ingredient True daratumumab Inferred relationship Some 418201394
daratumumab has intended active ingredient True daratumumab Inferred relationship Some 1
Darzalex 100 mg/5 mL injection, 5 mL vial has intended active ingredient True daratumumab Inferred relationship Some 753475412
Darzalex 100 mg/5 mL injection, 5 mL vial has Australian BoSS True daratumumab Inferred relationship Some 753475412
daratumumab 400 mg/20 mL injection, vial has Australian BoSS True daratumumab Inferred relationship Some 1662418220
daratumumab 400 mg/20 mL injection, vial has intended active ingredient True daratumumab Inferred relationship Some 1662418220
Darzalex (daratumumab 400 mg / 20 mL) injection, 20 mL vial (trade product unit of use) has intended active ingredient True daratumumab Inferred relationship Some 332583764
Darzalex (daratumumab 400 mg / 20 mL) injection, 20 mL vial (trade product unit of use) has Australian BoSS True daratumumab Inferred relationship Some 332583764
daratumumab 100 mg/5 mL injection, vial has intended active ingredient True daratumumab Inferred relationship Some 1241526572
daratumumab 100 mg/5 mL injection, vial has Australian BoSS True daratumumab Inferred relationship Some 1241526572
Daratumumab (Janssen) 100 mg/5 mL injection, 5 mL vial has intended active ingredient True daratumumab Inferred relationship Some 373262604
Daratumumab (Janssen) 100 mg/5 mL injection, 5 mL vial has Australian BoSS True daratumumab Inferred relationship Some 373262604
Daratumumab (Janssen) 400 mg/20 mL injection, 20 mL vial has Australian BoSS True daratumumab Inferred relationship Some 1630279372
Daratumumab (Janssen) 400 mg/20 mL injection, 20 mL vial has intended active ingredient True daratumumab Inferred relationship Some 1630279372

Reference Sets

Australian dialect reference set

Back to Start